Cargando…
Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
Use of newer antipsychotics for substitution of current antipsychotics might be one way awaiting to be clinically verified to address antipsychotic cardiotoxic effects. Alternatively, the combination of existing antipsychotics with cardioprotective agents is also beneficial for patients with mental...
Autores principales: | Liu, Zheng, Zhang, Mo-Lin, Tang, Xin-Ru, Li, Xiao-Qing, Wang, Jing, Li, Li-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476838/ https://www.ncbi.nlm.nih.gov/pubmed/36158311 http://dx.doi.org/10.5498/wjp.v12.i8.1108 |
Ejemplares similares
-
Antipsychotics cardiotoxicity: What's known and what's next
por: Li, Xiao-Qing, et al.
Publicado: (2021) -
Newer antipsychotics and the rabbit syndrome
por: Catena Dell'Osso, Mario, et al.
Publicado: (2007) -
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
por: Li, Liliang, et al.
Publicado: (2022) -
Antipsychotics and OCD: Boon or Bane?
por: Naguy, Ahmed
Publicado: (2017) -
Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents
por: Kannarkat, George T., et al.
Publicado: (2022)